[HTML][HTML] The emerging role of fatty acid binding protein 5 (FABP5) in cancers

WG Warren, M Osborn, A Yates, K Wright… - Drug Discovery …, 2023 - Elsevier
Highlights•Fatty acid binding protein 5 (FABP5) is a key regulator of cell metabolism and
growth that is overexpressed in cancers.•FABP5 facilitates the activation of transcriptional …

Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections

MS Draz, BA Fang, P Zhang, Z Hu, S Gu… - …, 2014 - pmc.ncbi.nlm.nih.gov
RNA interference (RNAi) is an endogenous post-transcriptional gene regulatory mechanism,
where non-coding, double-stranded RNA molecules interfere with the expression of certain …

Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers

M Amiri, S Yousefnia, FS Forootan, M Peymani… - Gene, 2018 - Elsevier
One of the most importantly involved pathways in cancer development is fatty-acid signaling
pathway. Synthesized lipids as energetic sources are consumed by cancer cells for …

[HTML][HTML] Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy

RZ Liu, K Graham, DD Glubrecht, DR Germain… - The American journal of …, 2011 - Elsevier
Recent studies using animal models suggest that expression of FABP5 drives the
stimulation of cell growth observed in estrogen receptor (ER)-negative breast cancer cells …

[HTML][HTML] FABP5 as a novel molecular target in prostate cancer

SE O'Sullivan, M Kaczocha - Drug Discovery Today, 2020 - Elsevier
Highlights•Fatty acid binding protein 5 (FABP5) is upregulated in many cancers, particularly
prostate cancer (PC).•FABP5 facilitates the delivery of fatty acids to peroxisome proliferator …

RankProd combined with genetic algorithm optimized artificial neural network establishes a diagnostic and prognostic prediction model that revealed C1QTNF3 as a …

Q Hou, ZT Bing, C Hu, MY Li, KH Yang, Z Mo, XW **e… - …, 2018 - thelancet.com
Prostate cancer (PCa) is the most commonly diagnosed cancer in males in the Western
world. Although prostate-specific antigen (PSA) has been widely used as a biomarker for …

Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter

FS Forootan, SS Forootan, X Gou, J Yang, B Liu… - …, 2016 - pmc.ncbi.nlm.nih.gov
In previous work, it is suggested that the excessive amount of fatty acids transported by
FABP5 may facilitate the malignant progression of prostate cancer cells through a FABP5 …

The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial‐to‐mesenchymal transition and lipid‐derived energy production in prostate …

RZ Liu, WS Choi, S Jain, D Dinakaran, X Xu… - Molecular …, 2020 - Wiley Online Library
Early stage localized prostate cancer (PCa) has an excellent prognosis; however, patient
survival drops dramatically when PCa metastasizes. The molecular mechanisms underlying …

A fatty acid‐binding protein 7/RXRβ pathway enhances survival and proliferation in triple‐negative breast cancer

RZ Liu, K Graham, DD Glubrecht, R Lai… - The Journal of …, 2012 - Wiley Online Library
FABP7 has been implicated in tumour cell proliferation, cell migration, and poor prognosis in
patients with high‐grade astrocytoma and melanoma. In this study, we examine FABP7 …

The role of peroxisome proliferator-activated receptor gamma in prostate cancer

C Elix, SK Pal, JO Jones - Asian journal of andrology, 2018 - journals.lww.com
Despite great progress in the detection and treatment of prostate cancer, this disease
remains an incredible health and economic burden. Although androgen receptor (AR) …